Published in AIDS on March 01, 1996
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One (2009) 2.51
Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med (2008) 2.33
Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis. Sci Transl Med (2012) 1.65
Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries. Bull World Health Organ (1997) 1.50
Tuberculosis control in resource-poor settings with high rates of HIV infection. Am J Public Health (1996) 1.06
Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania. BMC Res Notes (2008) 1.01
Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study. BMC Infect Dis (2010) 0.98
A situational analysis of antimicrobial drug resistance in Africa: are we losing the battle? Ethiop J Health Sci (2012) 0.97
Characteristics of multidrug-resistant tuberculosis in Namibia. BMC Infect Dis (2012) 0.94
Implementation of a national anti-tuberculosis drug resistance survey in Tanzania. BMC Public Health (2008) 0.90
Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996. J Natl Med Assoc (2000) 0.90
The economic burden to families of HIV and HIV/tuberculosis coinfection in a subsidized HIV treatment program. J Natl Med Assoc (2007) 0.85
Evaluation of task shifting in community-based DOTS program as an effective control strategy for tuberculosis. ScientificWorldJournal (2011) 0.84
Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. Elife (2016) 0.80
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (1998) 10.78
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? Int J Tuberc Lung Dis (2011) 5.14
Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet (1993) 4.96
GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature (1997) 4.49
Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Lond) (2000) 4.34
Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron (1996) 4.00
Secular trends of tuberculosis in western Europe. Bull World Health Organ (1993) 3.67
The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis (1987) 3.48
Tuberculosis elimination in the countries of Europe and other industrialized countries. Eur Respir J (1991) 3.46
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J (2009) 3.16
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med (1990) 2.68
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis (2008) 2.55
A lattice relaxation algorithm for three-dimensional Poisson-Nernst-Planck theory with application to ion transport through the gramicidin A channel. Biophys J (1999) 2.49
Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J (2010) 2.38
Scaling up tuberculosis culture services: a precautionary note. Int J Tuberc Lung Dis (2009) 2.35
Implicit and explicit memory for new associations in normal and amnesic subjects. J Exp Psychol Learn Mem Cogn (1985) 2.27
Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania. Lancet (1995) 2.17
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
An ecological analysis of incidence of tuberculosis and per capita gross domestic product. Eur Respir J (2008) 2.06
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice. Antimicrob Agents Chemother (2001) 1.98
Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis (2009) 1.92
A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem Pharmacol (1984) 1.90
Misbehaviour of a dying epidemic: a call for less speculation and better surveillance. Tuber Lung Dis (1992) 1.86
Tuberculosis trends in eastern Europe and the former USSR. Tuber Lung Dis (1994) 1.81
Redistribution and stabilization of cell surface glutamate receptors during synapse formation. J Neurosci (1997) 1.73
Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models. Int J Tuberc Lung Dis (2008) 1.72
Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis (1996) 1.70
Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med (1976) 1.63
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. J Clin Oncol (2001) 1.62
Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci (Lond) (2004) 1.62
Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J (2007) 1.62
Socialization patterns are key to the transmission dynamics of tuberculosis. Int J Tuberc Lung Dis (1999) 1.61
The information that amnesic patients do not forget. J Exp Psychol Learn Mem Cogn (1984) 1.60
Tuberculosis in children. Pediatr Infect Dis J (1988) 1.57
Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories. Int J Tuberc Lung Dis (2011) 1.56
The epidemiology of tuberculosis in the United States. Semin Respir Infect (1989) 1.52
A tuberculin skin test survey among Afghan children in Kabul. Int J Tuberc Lung Dis (2004) 1.47
Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci (1998) 1.46
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Scanty AFB smears: what's in a name? Int J Tuberc Lung Dis (2004) 1.45
Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998. Int J Tuberc Lung Dis (2001) 1.40
Tuberculosis elimination: are we willing to pay the price? Am J Respir Crit Care Med (2001) 1.38
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. Am J Respir Crit Care Med (1994) 1.35
Characterization of excitatory amino acid receptors expressed by embryonic chick motoneurons in vitro. J Neurosci (1986) 1.32
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice. Am J Respir Crit Care Med (1998) 1.30
Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months. Int J Tuberc Lung Dis (1998) 1.30
Performance and acceptability of the FluoLED Easy module for tuberculosis fluorescence microscopy. Int J Tuberc Lung Dis (2008) 1.26
Risk of occupational tuberculosis in National Tuberculosis Programme laboratories in Korea. Int J Tuberc Lung Dis (2007) 1.26
Critical appraisal of current recommendations and practices for tuberculosis sputum smear microscopy. Int J Tuberc Lung Dis (2007) 1.24
Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension (1990) 1.23
Sonography of the hand and foot in foreign body detection. J Ultrasound Med (1987) 1.23
Decreased flux through pyruvate dehydrogenase during calcium ion movements induced by vasopressin, alpha-adrenergic agonists and the ionophore A23187 in perfused rat liver. Biochem J (1983) 1.20
Swine-like influenza virus infection in a Wisconsin farm family. J Infect Dis (1977) 1.20
On the mechanism of acetylcholine receptor accumulation at newly formed synapses on chick myotubes. J Neurosci (1985) 1.19
Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy. Pediatr Infect Dis J (1992) 1.17
The epidemiology of tuberculosis in the United States. Implications for diagnosis and treatment. Clin Chest Med (1989) 1.16
Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J (2010) 1.15
Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys. Int J Tuberc Lung Dis (2011) 1.15
Seasonality of tuberculosis in an Eastern-Asian country with an extreme continental climate. Eur Respir J (2009) 1.14
A comparison of fluorescence microscopy with the Ziehl-Neelsen technique in the examination of sputum for acid-fast bacilli. Int J Tuberc Lung Dis (1999) 1.13
Completeness of AIDS reporting in Switzerland: a study based on deaths between December 1987 and June 1990. AIDS (1992) 1.13
Influenza-related mortality. JAMA (1978) 1.13
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens. Am J Respir Crit Care Med (2000) 1.13
Respiratory status of surface coal miners in the United States. Arch Environ Health (1977) 1.12
Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia (1975) 1.11
Tuberculosis and the acquired immunodeficiency syndrome. Chest (1986) 1.11
Remission of Crohn's disease with antimycobacterial chemotherapy. Lancet (1987) 1.10
Evaluation of the MycoDot test in patients with suspected tuberculosis in a field setting in Tanzania. Int J Tuberc Lung Dis (1999) 1.09
HIV-1 infection as a risk factor for leprosy; a case-control study in Tanzania. Int J Lepr Other Mycobact Dis (1993) 1.09
An inhibitor of mitochondrial respiration which binds to cytochrome b and displaces quinone from the iron-sulfur protein of the cytochrome bc1 complex. J Biol Chem (1984) 1.08
Episodic spatial memory in adulthood. Psychol Aging (1993) 1.08
[Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Gesundheitswesen (2007) 1.08
The quality of sputum smear microscopy diagnosis of pulmonary tuberculosis in Dar es Salaam, Tanzania. Tanzan Health Res Bull (2007) 1.07
Disease due to Mycobacterium avium-intracellulare. Chest (1985) 1.06
Using other people's graphs. Int J Tuberc Lung Dis (2001) 1.06
Tuberculosis in an Indochinese refugee camp: epidemiology, management and therapeutic results. Tubercle (1985) 1.05
Quantification of the alpha- and gamma-tocopherol metabolites 2,5,7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman and 2,7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman in human serum. Anal Biochem (1999) 1.05
Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Clin Exp Allergy (1995) 1.04
Excitatory synaptic transmission between interneurons and motoneurons in chick spinal cord cell cultures. J Neurosci (1986) 1.02
The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries. Int J Tuberc Lung Dis (1998) 1.02
Hepatic calcium efflux during cytochrome P-450-dependent drug oxidations at the endoplasmic reticulum in intact liver. Proc Natl Acad Sci U S A (1981) 1.02
Priming across modalities and priming across category levels: extending the domain of preserved function in amnesia. J Exp Psychol Learn Mem Cogn (1985) 1.02
Completeness and consistency in recording information in the tuberculosis case register, Cambodia, China and Viet Nam. Int J Tuberc Lung Dis (2010) 1.02
Kawasaki disease in the United States. J Infect Dis (1978) 1.02
Nationwide survey of anti-tuberculosis drug resistance in Mongolia. Int J Tuberc Lung Dis (2011) 1.01
[Recommendations for background studies in tuberculosis]. Pneumologie (2007) 1.01
Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob Agents Chemother (1991) 1.01
Risk factors for Campylobacter enteritis in Switzerland. Zentralbl Hyg Umweltmed (1994) 1.00
Changes in body weight and tuberculosis treatment outcome in Viet Nam. Int J Tuberc Lung Dis (2012) 1.00
Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. East Afr Med J (1999) 1.00
Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China. Int J Tuberc Lung Dis (2013) 0.99
Efficiency of a third serial sputum smear examination in the diagnosis of tuberculosis in Moldova and Uganda. Int J Tuberc Lung Dis (2007) 0.98
The prevalence of coal workers' pneumoconiosis in US coal miners. Arch Environ Health (1973) 0.98